A Founder Effect in the Newfoundland Population Reduces the Bardet-Biedl Syndrome I (BBS1) Interval to 1 cM  by Young, Terry-Lynn et al.
Am. J. Hum. Genet. 65:1680–1687, 1999
1680
A Founder Effect in the Newfoundland Population Reduces
the Bardet-Biedl Syndrome I (BBS1) Interval to 1 cM
Terry-Lynn Young,1 Michael O. Woods,1 Patrick S. Parfrey,1 Jane S. Green,1 Donna Hefferton,1
and William S. Davidson2
1Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland, and 2Institute of Molecular Biology and
Biochemistry, Simon Fraser University, Burnaby, British Columbia
Summary
Bardet-Biedl syndrome (BBS) is a rare, autosomal re-
cessive disorder; major phenotypic findings include dys-
morphic extremities, retinal dystrophy, obesity, male hy-
pogenitalism, and renal anomalies. In the majority of
northern European families with BBS, the syndrome is
linked to a 26-cM region on chromosome 11q13. How-
ever, the finding, so far, of five distinct BBS loci (BBS1,
1q; BBS2, 16q; BBS3, 3p; BBS4, 15q; BBS5, 2q) has
hampered the positional cloning of these genes. We use
linkage disequilibrium (LD) mapping in an isolated
founder population in Newfoundland to significantly re-
duce the BBS1 critical region. Extensive haplotyping in
several unrelated BBS families of English descent re-
vealed that the affected members were homozygous for
overlapping portions of a rare, disease-associated an-
cestral haplotype on chromosome 11q13. The LD data
suggest that the BBS1 gene lies in a 1-Mb, sequence-
ready region on chromosome 11q13, which should en-
able its identification.
Introduction
Bardet-Biedl syndrome (BBS; MIM 209900) is a rare,
autosomal recessive disorder in which the combination
of dysmorphic extremities, retinal dystrophy, obesity,
male hypogenitalism, and renal anomalies may be as-
sociated, to varying degrees, with mental retardation
and/or diabetes mellitus (Green et al. 1989; O’Dea et al.
1996). Of the five genetic subtypes, BBS1 appears to be
the most common locus in affected individuals of north-
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ern European descent: as many as 50% of pedigrees
show linkage to BBS1 (Beales et al. 1997; Bruford et al.
1997; Woods et al. 1999). BBS1 was initially mapped
to chromosome 11q13 by combining the positive LOD
scores achieved in 17 of 31 North American kindreds
as a result of a genome scan (Leppert et al. 1994). The
other BBS loci, BBS2 (16q; Kwitek-Black et al. 1993),
BBS3 (3p; Sheffield et al. 1994), BBS4 (15q; Carmi et
al. 1995) and BBS5 (2q; Young et al. 1999), were located
by homozygosity mapping in extended inbred kindreds.
In the original study by Leppert et al. (1994), the pu-
tative BBS1 gene was tightly linked to two loci on chro-
mosome 11q13: the gene for human muscle glycogen
phosphorylase (PYGM) and the anonymous DNA mar-
ker D11S913 (AFM164zf12), and was localized to a 26-
cM interval between D11S1298 and INT2 (FGF3). A
more precise genetic and physical location of BBS1 is
required if the BBS1 gene is to be positionally cloned.
Refined mapping of disease genes has recently been
accomplished by linkage disequilibrium (LD) mapping
in founder populations (reviewed by Jorde 1995 and by
Xiong and Guo 1997). When a disease mutation is first
introduced into a population, it resides on a single dis-
ease haplotype (DH) of linked markers. As a result of
meiotic recombination, the length of this DH decreases
as a function of genetic distance so that, with successive
generations, only the original marker alleles in the vi-
cinity of the disease locus cosegregate on disease chro-
mosomes. Although fine mapping of disease genes was
established initially in old populations like the Finnish
(Hastbacka et al. 1992), recent success in fine mapping
has been accomplished in relatively young populations
(Labuda et al. 1996; Groenewald et al. 1998). The island
population of Newfoundland, considered a genetic iso-
late because of the nature of its founding and subsequent
isolation, is enriched for BBS, with 10 times the incidence
in other white populations of northern European an-
cestry (Green et al. 1989; O’Dea et al. 1996). A single
founder effect has been reported in two recent studies
of families from the island with either hereditary non-
polyposis colorectal cancer (HNPCC) or multiple en-
docrine neoplasia type 1 (MEN1) (Olufemi et al. 1998;
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Table 1
DHs on Chromosome 11q13 Segregating in Six BBS Families
MARKER
B7 B8 B10 B12 B15 B19
p m p m p m p m p m p m
D11S1298 7 3 10 10 7 10 7 9 11 11 ) )
D11S956 6 8 8 8 10 8 7 5 7 7 11 11
D11S480 9 5 6 6 9 6 5 9 5 5 9 9
D11S1883 10 10 10 10 10 10 10 8 10 10 7 7
D11S913 6 7 7 7 6 7 6 5 6 6 6 6
FGF3 7 12 5 5 7 5 9 9 9 9 ) )
NOTE.—Haplotypes are arranged with the paternal haplotype (p) on the left and the maternal
haplotype (m) on the right. For markers D11S913 and FGF3, the phase of the paternal hap-
lotype in B12 is assumed.
Froggatt et al. 1999). In the present study we show that,
in five unrelated families from Newfoundland, the family
members affected with BBS are homozygous for an an-
cestral DH, and we use recent and historical recombi-
nations to the ancestral DH to map theBBS1 gene within
a 1-Mb region on chromosome 11q13.
Subjects and Methods
Subjects
In a recent population survey, 17 BBS families of Eng-
lish ancestry were haplotyped at the BBS1, BBS2, BBS3,
and BBS4 loci. Of these families, three (B8, B10, and
B19) were assigned to BBS1 and three (B7, B12, and
B15) could not be excluded from this locus because they
yielded positive LOD scores and haplotypes consistent
with linkage to BBS1 (Woods et al. 1999; table 1). Of
these six families, parental consanguinity was docu-
mented in family B8 and suspected in families B10, B12,
B15, and B19 on the basis of progenitors with the same
surname originating from the same community. Exten-
sive genotyping with markers mapping to the BBS1 crit-
ical region was performed in the six families, repre-
senting 8 BBS patients and 44 first- and second-degree
relatives. Informed consent had been obtained previ-
ously, and the clinical presentations of the adult patients
have been described elsewhere (Green et al. 1989; O’Dea
et al. 1996).
Genotyping
DNA was extracted from the lymphocytes of venous
blood by a simple salting-out procedure (Miller et al.
1988). Fifty to 100 ng of template DNA in standard 10-
mL reactions containing 1.5 pmol of primer, 200 mm
dNTPs, 0.125 units of Tf1 DNA polymerase, and a trace
amount of g[32P] end-labeled forward primer was am-
plified by temperature cycling in a Perkin Elmer 9600
thermocycler. Products were run on 6%–8% polyacryl-
amide sequencing gels with formamide (Litt et al. 1993)
and were subjected to autoradiography. The markers
D11S1298, D11S956, D11S480, D11S4205,
D11S1883, D11S4945, PYGM, D11S4946, D11S4940,
D11S4938, D11S449, D11S4941, D11S913, and FGF3
were typed in key family members. Family B7 was ex-
cluded from the study, because several samples failed to
amplify.
Family Studies
Haplotypes were constructed, for each family, to give
the minimum number of recombinations. DHs were
identified from alleles that were transmitted from both
unaffected parents to affected offspring. Pairwise linkage
analyses between BBS and six markers spanning the
BBS1 critical region were performed under an autosomal
recessive model with a penetrance of 0.95 and a disease-
allele frequency of .004. The disease-allele frequency for
BBS was calculated from the Newfoundland population
estimate of 1/17,500 (Green et al. 1989), adjusted to
reflect an estimated 50% contribution of the BBS1 locus
to the overall population frequency. All markers were
assumed to have nine alleles of equal frequency in the
population. LOD scores were calculated by the MLINK
subroutine program of FASTLINK (V3.0P) (Lathrop
and Lalouel 1984; Cottingham et al. 1993; Scha¨ffer et
al. 1994).
Population Studies
The marker-allele frequencies in disease and normal
(nontransmitted) chromosomes of the 10 obligate BBS
carriers (parents) were compared. Normal alleles from
each parent were used as population controls, to avoid
the possibility of inadvertently including BBS1 disease
alleles from random carriers in the population. Allelic
association was tested by means of Fisher’s exact test,
with one-sided probability. The DHs were compared be-
tween families in the search for (i) common BBS1 hap-
lotypes that would indicate that the parents of two or
more families were distantly related and (ii) a common
ancestral DH.
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Figure 1 Geographical distribution of 17 Newfoundland fami-
lies with BBS (blackened circles), indicating linkage with BBS1, BBS3,
or BBS5 as determined in previous studies (Woods et al. 1999; Young
et al. 1999). The families genotyped in the present study are indicated
by family number.
Results
Preliminary Evidence of a Founder Effect among
Families with BBS1
Five of the six families in this study live along the
south and southwest coasts of Newfoundland (fig. 1).
Although a common ancestor was not identified in an-
cestral lineages, genetic evidence suggests that the fam-
ilies are interrelated. The affected individuals in family
B10 are apparently heterozygous for a copy of the DH
identified in family B8 and a portion of the DH trans-
mitted by the father of family B7 (table 1). It was noted
that these three families originate from closely-linked
communities on the southwest coast of the island (fig.
1). The data also suggest that the father of a south coast
family (B12) shares a recent common ancestor with both
parents of family B15, the only family not residing on
the south coast of the island. Therefore, on the basis of
shared DHs and geographical location, preliminary ev-
idence suggested the presence of a founder effect among
BBS1 cases in the Newfoundland population.
Evidence of Linkage to BBS1
In a previous study, three families (B8, B10, and B19)
were assigned to BBS1 (Woods et al. 1999, table 1).
Family B10 consists of a large sibship in which two
affected individuals share a unique genotype on chro-
mosome 11q13, compared with their nine unaffected
sibs (fig. 2). A maximum LOD score of 1.662 at recom-
bination fraction (v) 0 was obtained with fully infor-
mative markers that mapped telomeric to D11S1883.
Family B10 was previously excluded from linkage with
BBS2, BBS3, BBS4 (Woods et al. 1999), and BBS5 (M.
O. Woods, unpublished data) on the basis of established
exclusion criteria. For a locus to be excluded, one or
both of the following conditions had to be met: (i) an
affected individual(s) inherited the same genotype as one
or more unaffected sibs, and (ii) two or more affected
individuals inherited different genotypes. Family B8 is a
consanguineous family in which a single affected off-
spring was homozygous by descent (HBD) for the entire
BBS1 locus (fig. 2). A maximum LOD score of 1.405
( ) was obtained with fully informative markersv = 0
(e.g., D11S1883). Homozygosity (in the affected mem-
ber only) was not observed at other BBS loci: BBS2 and
BBS3 loci were excluded. Family B19 consists of a large
sibship with one affected individual. The affected off-
spring was homozygous (presumably HBD) for all mark-
ers typed within the BBS1 interval, whereas seven un-
affected sibs were either heterozygous or homozygous
for a normal haplotype. Homozygosity was not observed
at other BBS loci, and the BBS3 locus could be excluded
(Woods et al. 1999).
In three families (B7, B12, and B15), BBS could not
be excluded from, or confidently assigned to, the BBS1
locus (Woods et al. 1999). Family B15 consists of a large
sibship with one affected and eight unaffected sibs avail-
able for genotyping. Homozygosity in the affected in-
dividual was observed only at the BBS1 locus, and the
BBS3 locus could be excluded. Family B7 has two af-
fected individuals who share a unique genotype on chro-
mosome 11q13, compared with their four unaffected
sibs (fig. 2). A maximum LOD score of 1.074 ( )v = 0
was obtained with fully informative markers, and BBS
in this family was excluded from linkage to BBS3, BBS4,
and BBS5 (M. O. Woods, unpublished data). Family B12
is relatively uninformative for linkage but was excluded
from BBS3 because the only affected individual (PID 14)
inherited the same genotype as his unaffected sister. He
is homozygous for the BBS1 marker D11S913, but the
phase of the paternal chromosomes cannot be deter-
mined for the D11S913-FGF3 interval because of an
apparent recombination in one of the offspring.
The pairwise LOD scores calculated for the six fam-
ilies at six markers covering the 26-cM BBS1 critical
region were summed. Four of six markers examined
reached statistical significance when the families were
considered together (LOD score 13; table 2). The finding
of common DHs among BBS1-assigned families (B8 and
B10), between BBS1-assigned and unassigned families
(B7 and B10), and among unassigned families with ev-
idence of linkage to BBS1 (B12 and B15) (table 1) cor-
roborates the linkage and haplotype data that these are,
Figure 2 Three families with linkage to BBS1 (B8, B10 and B19) and three unassigned families (B7, B12, and B15) haplotyped for six
polymorphic markers spanning the 26-cM BBS1 interval on chromosome 11q13. Only core pedigrees are presented. Blackened symbols indicate
individuals with diagnoses of BBS. Boxed haplotypes (solid and dashed lines) indicate DHs. Double marriage lines depict consanguineous unions,
either documented (solid line) or suspected (dashed line). “R” indicates that the DH is recombinant.
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Table 2
Sum of the Pairwise LOD Scores at Chromosome 11q13, in Six
Families with BBS
MARKER
LOD SCORE AT v=
.000 .010 .050 .100 .200 .300 .400
D11S1298 2.227 2.263 2.169 1.856 1.124 .052 .142
D11S956 3.419 3.439 3.275 2.867 1.910 .972 .279
D11S480 2.809 2.819 2.623 2.202 1.288 .559 .137
D11S1883 3.657 3.663 3.430 2.952 1.868 .894 .241
D11S913 3.019 2.923 2.546 2.093 1.264 .587 .151
FGF3 3.777 3.662 3.203 2.644 1.599 .739 .190
Figure 3 Refinement of the BBS1 interval by recombinational
and LD mapping in Newfoundland families. The markers and their
relative positions were selected from the map of the MEN1 region on
11q13 (Manickam et al. 1997; Sixth International SCW 11 Workshop
1998).
in fact, all BBS1 families. Because the exact relationships
among the pedigrees are unknown, the summary LOD
scores given in table 2 are presumed to be underesti-
mated. Obligate recombinations involving the DHs were
detected in several families and used to refine the BBS1
interval. In family B10, an unaffected individual, PID
14, inherited a nonrecombinant DH from his father and
a recombinant DH from his mother. The presence of
two DHs for the centromeric portion of theBBS1 critical
region (D11S1298 to D11S1883) in an unaffected in-
dividual suggests that marker D11S1883 is the new cen-
tromeric boundary for BBS1 (fig. 2). Similarly, a recom-
binant paternal haplotype inherited by an unaffected sib
in family B8 (PID 12) suggests that BBS1 is located cen-
tromeric to FGF3. Intrafamilial recombinations on DHs
reduce the BBS1 interval from a 26-cM region to a 15-
cM interval between D11S1883 and FGF3 (fig. 3).
LD and Detection of a Founder Haplotype
Extensive genotyping at the BBS1 locus focused on
markers within the new BBS1 interval (fig. 3). The dis-
tribution of alleles at 14 polymorphic loci in disease
and normal chromosomes is shown in table 3. Signifi-
cant LD between specific marker alleles on DHs was
observed across the families. Strong associations were
observed between alleles at five consecutive marker
loci: D11S4205, D11S1883, D11S4945, PYGM, and
D11S4946. Comparison of allele frequencies between
disease and normal chromosomes showed that three of
these associations were statistically significant. Allele 10
at markerD11S1883 was present on 70% (7/10) of DHs
but only 20% (2/10) of normal chromosomes ( ).P ! .05
Similarly, allele 8 at the PYGM locus was present on
100% of the DHs and 50% of normal chromosomes
( ), and allele 5 at marker D11S4946 was presentP ! .05
on 100% of the disease chromosomes and 30% of nor-
mal chromosomes ( ). Although allele 4 at markerP ! .01
D11S4205 and allele 9 at marker D11S4945 were pre-
sent on 90% and 100% of disease chromosomes, re-
spectively, these associations were not significant, be-
cause both alleles are common in the general population;
they are present on 70% of the normal chromosomes
(table 3).
A single ancestral DH was readily identified in the
vicinity of marker loci with strong allelic associations.
All disease chromosomes segregating in BBS1 families
contained the -9-8-5- subhaplotype at D11S4945,
PYGM, and D11S4946, respectively. The affected mem-
bers in families B10 and B12 that initially appeared to
be heterozygous at the BBS1 locus (table 1) are, in fact,
HBD for a region centered around the PYGM locus (ta-
ble 3). As well, the DHs that appeared unique on the
basis of six polymorphic markers (e.g., family B19, table
1) are indistinguishable from all other DHs identified in
the population. In contrast, the -9-8-5- subhaplotype
was found only on a single normal haplotype (family
B8). This suggest that, although rare, the -9-8-5- sub-
haplotype is not exclusive to BBS1-carrying chromo-
somes in the Newfoundland population. The longer - 4-
10-9-8-5- haplotype (encompassing the -9-8-5-
subhaplotype and the centromeric markers D11S4205
and D11S1883) was identified on 60% of the DHs but
none of the normal chromosomes. This longer haplotype
may represent a larger portion of the ancestral DH. In
this case, DHs discordant for allele 10 at D11S1883
(families B12 and B19) may have resulted from either
Young et al.: BBS1 Interval Reduced to 1 cM 1685
Table 3
LD at the BBS1 Locus on Chromosome 11q13 among Five Newfoundland Kindreds
LOCUS
DH FOR KINDRED NORMAL HAPLOTYPE FOR KINDRED
B8 B10 B12 B15 B19 B8 B10 B12 B15 B19
p m p m p m p m p m p m p m p m p m p m
1298 10 10 7 10 7 9 11 11 ) ) 5 7 10 7 4 7 8 13 ) )
956 8 8 10 8 7 5 7 7 11 11 10 3 11 7 1 2 5 6 11 7
480 6 6 9 6 5 9 5 5 9 9 9 5 5 5 6 5 8 5 4 5
4205 4 4 3 4 4 4 4 4 4 4 3 4 4 5 4 4 3 4 4 4
1883 10 10 10 10 10 8a 10 10 7 7 9 12 12 9 13 10 12 11 10 7
4945 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 4 10 10 9 9
PYGM 8 8 8 8 8 8 8 8 8 8 8 8 6a 8 2 4 4 8 8 4
4946 5 5 5 5 5 5 5 5 5 5 4 5 5 4 4 1 1 5 3 3
4940 5 5 7 5 7 5 7 7 3 3 5 5 5 5 5 3 5 7 7 5
4938 5 5 3 5 5 3 5 5 5 5 9 3 5 3 5 9 5 5 ) 9
449 7 7 3 7 3 6 5 5 3 3 5 3 4 3 4 2 5 5 3 4
4941 9 9 11 9 2 2 4 4 4 4 8 3 6 11 2 4 4 6 4 4
913 7 7 6 7 6 5 6 6 6 6 7 6 5 5 5 7 6 6 7 6
FGF3 5 5 7 5 9 9 9 9 ) ) 4 5 5 9 5 5 12 5 ) )
NOTE.—Haplotypes are arranged with paternal haplotype (p) on the left and the maternal haplotype (m) on the right. Specific alleles associated
with disease chromosomes are boxed.
a Allele is not associated with disease chromosome.
(i) historical recombinations to the ancestral DH be-
tween D11S1883 and D11S4945 that were not infor-
mative at D11S4205, a notably uninformative marker
in the population, or (ii) de novo mutations at the more
polymorphic D11S1883 locus. In any case, the evidence
suggests that the -9-8-5- subhaplotype represents either
the remnants of a founder BBS1 chromosome imported
from England or the background haplotype that sus-
tained a BBS1 mutation de novo in the germline of a
single English settler.
Location of BBS1
LD mapping supports a position for the BBS1 gene
within a 1-cM region between markers D11S1883 and
D11S4940, surrounding the PYGM locus. The
D11S1883 boundary is also supported on the basis of
intrafamilial recombination (fig. 3). This 1-cM genetic
interval represents a physical distance of ∼1 Mb (Man-
ickam et al. 1997) within a region of the genome that
is gene rich and, fortuitously, sequence ready as a result
of physical mapping efforts to clone the Best vitelliform
macular dystrophy (VMD-2) and multiple endocrine
neoplasia (MEN1) genes that map to this region (Cooper
et al. 1997; Guru et al. 1997; Manickam et al. 1997).
Discussion
The island of Newfoundland is a sparsely populated
region of Canada in which 50% of the population of
560,000 reside in small coastal communities. The col-
onization of the island occurred primarily by a natural
increase from northern European settlers of predomi-
nantly English and Irish extraction who arrived before
1835. Most founders originated from the West Country
of England and from southeast Ireland (Mannion 1977).
Mating segregation between Irish Catholics and English
Protestants, low immigration, and geographical isola-
tion of communities have resulted in genetic isolation of
the population. In a review of the historical development
of genetic isolation in three Newfoundland outports,
Bear et al. (1988) observed that only 1%–8% of breed-
ing parents were immigrants to the area and 60% of
births had been to parents originating from the same
small community.
The scattered distribution of families with BBS and
the recent identification of at least three distinct genetic
BBS subtypes in Newfoundland (Woods et al. 1999) is
not consistent with the expectation of a single cluster of
families with a recessive disease in a young founder pop-
ulation. However, we noted that five of the six families
with evidence of linkage to BBS1 reside on the south
and southwest coasts of the island, a region that was
settled predominantly by the spread of settlers by sea in
an east-to-west direction (Mannion 1977). The geno-
typing data also suggest that these families have complex
relationships with each other in that large regions (up
to 26 cM) on disease-associated haplotypes were shared
among kindreds. In the absence of mutation analysis,
the identification of a single founder effect would require
that all patients were homozygous for specific alleles at
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marker loci tightly linked to the BBS1 gene. We have
shown that all BBS1 patients identified in the New-
foundland population are homozygous for a relatively
rare haplotype spanning a 1-cM region centered around
the PYGM gene on chromosome 11q13. The relatively
high incidence of BBS and the scattered distribution of
affected families in the Newfoundland population are
attributable to a combination of locus heterogeneity and
at least one founder effect.
The power of LD mapping is well illustrated from this
study: a total of six affected individuals in five families
were used to fine map the BBS1 gene to within 1 Mb
by this method. Even families not informative for linkage
(e.g., B12) provided valuable information on historical
recombinations. In contrast, two recent studies reporting
on a total of 47 families with BBS failed to identify
informative recombinations at the BBS1 locus (Beales
et al. 1997; Bruford et al. 1997). The localization of
BBS1 within a 1-Mb interval between D11S1883 and
D11S4940 is small enough to promote the positional
cloning of the BBS1 gene. The Newfoundland popula-
tion may also be useful for the analysis of other genetic
diseases, especially those that have a relatively high in-
cidence in the population: nonsyndromic deafness, var-
ious forms of retinal dystrophy, neuronal ceroid lipo-
fuscinosis, and neural tube defects (J. Green, unpub-
lished data).
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